Tenax Therapeutics, Inc. (TENX) DCF Valuation

Tenax Therapeutics, Inc. (Tenx) DCF Valoración

US | Healthcare | Biotechnology | NASDAQ
Tenax Therapeutics, Inc. (TENX) DCF Valuation
  • ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
  • ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
  • ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
  • ✓ No Se Necesita Experiencia; Fáciles De Seguir

Tenax Therapeutics, Inc. (TENX) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Diseñada para la precisión, nuestra calculadora DCF de Tenax Therapeutics, Inc. (Tenx) le permite evaluar la valoración de Tenax Therapeutics utilizando datos financieros actualizados, proporcionando una flexibilidad completa para modificar todos los parámetros esenciales para las proyecciones mejoradas.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 0 0 0 0 0 0 0 0 0
EBITDA -8.3 -9.7 -32.4 -10.9 -8.2 .0 .0 .0 .0 .0
EBITDA, % 100 100 100 100 100 100 100 100 100 100
Depreciation .1 .1 .1 .1 .0 .0 .0 .0 .0 .0
Depreciation, % 100 100 100 100 100 100 100 100 100 100
EBIT -8.4 -9.8 -32.5 -11.0 -8.2 .0 .0 .0 .0 .0
EBIT, % 100 100 100 100 100 100 100 100 100 100
Total Cash 5.4 6.7 5.6 2.1 9.8 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 .0 .0 .0
Account Receivables, % 100 100 100 100 100
Inventories .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Inventories, % 100 100 100 100 100 100 100 100 100 100
Accounts Payable 1.7 .8 .9 .4 2.1 .0 .0 .0 .0 .0
Accounts Payable, % 100 100 100 100 100 100 100 100 100 100
Capital Expenditure .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 100 100 100 0 0 0 0 0
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -8.4 -9.9 -32.7 -11.0 -8.2 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -6.6 -10.7 -32.5 -11.3 -6.6 -2.1 .0 .0 .0 .0
WACC, % 12.23 12.23 12.23 12.23 12.23 12.23 12.23 12.23 12.23 12.23
PV UFCF
SUM PV UFCF -1.8
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value -2
Net Debt -9
Equity Value 7
Diluted Shares Outstanding, MM 0
Equity Value Per Share 29.96

What You Will Get

  • Real Tenax Data: Preloaded financials – from revenue to EBIT – based on actual and projected figures for Tenax Therapeutics, Inc. (TENX).
  • Full Customization: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates specific to Tenax Therapeutics, Inc. (TENX).
  • Instant Valuation Updates: Automatic recalculations to analyze the impact of changes on Tenax Therapeutics, Inc. (TENX)’s fair value.
  • Versatile Excel Template: Tailored for quick edits, scenario testing, and detailed projections for Tenax Therapeutics, Inc. (TENX).
  • Time-Saving and Accurate: Skip building models from scratch while maintaining precision and flexibility for Tenax Therapeutics, Inc. (TENX).

Key Features

  • Comprehensive Data: Tenax Therapeutics' historical financial records and pre-populated projections.
  • Customizable Parameters: Modify WACC, tax rates, revenue growth, and EBITDA margins to fit your analysis.
  • Real-Time Updates: Observe Tenax Therapeutics' intrinsic value recalculating instantly.
  • Intuitive Visualizations: Dashboard graphs illustrate valuation outcomes and essential metrics.
  • Designed for Precision: A robust tool tailored for analysts, investors, and finance professionals.

How It Works

  • Download: Obtain the pre-built Excel file containing Tenax Therapeutics, Inc.'s (TENX) financial data.
  • Customize: Modify forecasts, such as revenue growth, EBITDA %, and WACC.
  • Update Automatically: The intrinsic value and NPV calculations refresh in real-time.
  • Test Scenarios: Generate various projections and instantly compare results.
  • Make Decisions: Utilize the valuation findings to inform your investment approach.

Why Choose This Calculator for Tenax Therapeutics (TENX)?

  • User-Friendly Interface: Perfectly crafted for both novice users and seasoned professionals.
  • Customizable Inputs: Adjust parameters effortlessly to tailor your financial analysis.
  • Real-Time Valuation: Monitor immediate updates to Tenax’s valuation as you change inputs.
  • Preloaded Data: Comes with Tenax’s latest financial information for swift evaluations.
  • Favored by Experts: Utilized by analysts and investors for making well-informed investment choices.

Who Should Use This Product?

  • Individual Investors: Gain insights to make informed decisions about buying or selling Tenax Therapeutics stock (TENX).
  • Financial Analysts: Enhance valuation methodologies with easy-to-use financial models tailored for Tenax Therapeutics.
  • Consultants: Provide clients with accurate and timely valuation assessments for Tenax Therapeutics.
  • Business Owners: Learn how biopharmaceutical companies like Tenax Therapeutics are valued to inform your own business strategies.
  • Finance Students: Explore valuation principles using real-time data and case studies related to Tenax Therapeutics.

What the Template Contains

  • Pre-Filled Data: Includes Tenax Therapeutics, Inc.'s (TENX) historical financials and projections.
  • Discounted Cash Flow Model: Editable DCF valuation model featuring automatic calculations.
  • Weighted Average Cost of Capital (WACC): A dedicated sheet for WACC calculations based on customized inputs.
  • Key Financial Ratios: Assess Tenax Therapeutics, Inc.'s (TENX) profitability, efficiency, and leverage.
  • Customizable Inputs: Easily modify revenue growth, margins, and tax rates.
  • Clear Dashboard: Visuals and tables summarizing essential valuation outcomes.

No products were found matching.